Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 14.91 |
| PEG Ratio (TTM) | N/A | 3.53 |
| P/S Ratio (TTM) | N/A | 3.67 |
| P/B Ratio (TTM) | N/A | 6.18 |
| P/FCF Ratio (TTM) | N/A | 8.61 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.53 |
| Price to 5YR AVG FCF Ratio | 0.05 | -22.47 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 2.78% |
| ROE (TTM) | N/A | 45.48% |
| Net Profit Margin (TTM) | N/A | 28.90% |
| ROIC 5YR AVG | 9.45% | 23.94% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.53% | -69.89% | 185.03% |
| Revenue | -0.01% | -7.68% | -4.04% |
| Net Income | 1.21% | -69.72% | 184.49% |
| Cash Flow | 135.49% | 283.46% | 155.61% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 1.09 |
| Quick Ratio (TTM) | N/A | 0.29 |
| D/E Ratio (TTM) | N/A | 0.70 |
| Interest Coverage (TTM) | N/A | 22.52 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 0.95 | 0.76 |
| LTL to 5YR AVG FCF | 3.47 | -2.16 |
| Shares Outstanding Growth 5YR AVG | 0.29% | 30.37% |